Postbariatric EArly discharge Controlled by Healthdot - PEACH

Philips Research0 个研究点目标入组 200 人开始时间: 待定最近更新: 2024年4月15日

试验速览

暂无简介。

•- Adult (equal or greater than 18)
•- Approval for primary bariatric surgery (gastric sleeve or bypass) by a
•multidisciplinary bariatric team
•- Willing and able to sign informed consent form
•- Able to understand instructions
•- In possession of a telephone on which patient can be reached for the duration
•of participation (day 1-8)
•- An adult person must be present at the same location as the patient during
•the first night following surgery who is able to mobilize help or seek medical
•care if necessary.

•- Patients of psychiatric wards, inmates of prisons, or other state institutions
•- Investigator or any other team member involved directly or indirectly in the
•conduct of the clinical study
•- Any skin condition, for example prior rash, discoloration, scars or open
•wounds at the area (lower left rib) where the HealthDot needs to be placed
•- Known allergy for the tissue adhesive used in the Healthdot (white band-aid)
•- Use of topical that is known to influence the skin at the test area (such as
•medical and non-medical creams or lotions)
•- Patient with active implantable such as Implantable Cardioverter
•Defibrillator (ICD) and pacemaker
•- Expected participation less than 8 days
•- Left lower rib (place where Healthdot will be applied) is involved in the
•area of surgery, area of disinfection or area where bandages are needed.
•- Patients with antibiotic resitant infections (e.g. MRSA)

发起方